A small study found that the popular weight loss drug semaglutide may help lower the risk of developing cardiovascular disease. After one year, study participants showed improvements in multiple cardiovascular risk factors, including blood pressure,...
 
Daily News
 
 
April 25, 2024
Today’s top story
After One Year, Popular Weight Loss Drug Semaglutide (Wegovy/Ozempic) Improved Heart Health
A small study found that the popular weight loss drug semaglutide may help lower the risk of developing cardiovascular disease. After one year, study participants showed improvements in multiple cardiovascular risk factors, including blood pressure,...
Read on →
 
 
 
Psoriatic Arthritis Medication Brepocitinib Reduced Symptoms by 20% in Phase 2 Trial
 
Psoriatic Arthritis Medication Brepocitinib Reduced Symptoms by 20% in Phase 2 Trial
Read ON →
 
How a Breakthrough Treatment Helped ‘Cure’ This Man of HIV
 
How a Breakthrough Treatment Helped ‘Cure’ This Man of HIV
Read ON →
 
Genetic Tendency Toward Higher Blood Pressure and Cholesterol May Increase Alzheimer’s Risk, Study Suggests
 
Genetic Tendency Toward Higher Blood Pressure and Cholesterol May Increase Alzheimer’s Risk, Study Suggests
Read ON →
 
More top Reads
 
 
 
 
 
Advertisement
Start a custom weight loss program
Noom helps you adopt healthy habits so you can lose weight and keep it off.
GET STARTED →
 
 
 
 
Healthine
fb   tw   insta
View in browser

Did a friend send you this email? Subscribe here.
To see all newsletters, click here.

Privacy  |  Unsubscribe

Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health.

© 2023 Healthline Media LLC
275 7th Ave., 24th Floor
New York, NY 10001